Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05688670Phase 4Completed
Phase 4, randomised, double-blind trial of ropivacaine in procedural pain (2 arms), sponsored by Duke University. Primary endpoint: Total Amount of Opioid Medications Administered at 12 hours. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05688670.